Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 491-67-8
2. 5,6,7-trihydroxyflavone
3. Noroxylin
4. 5,6,7-trihydroxy-2-phenyl-4h-chromen-4-one
5. 5,6,7-trihydroxy-2-phenylchromen-4-one
6. Baikalein
7. Baicelein
8. Mfcd00017459
9. 5,6,7-trihydroxy-2-phenyl-chromen-4-one
10. 4h-1-benzopyran-4-one, 5,6,7-trihydroxy-2-phenyl-
11. Nsc661431
12. Nsc-661431
13. Chembl8260
14. Chebi:2979
15. 5,6,7-trihydroxy-2-phenyl-4h-1-benzopyran-4-one
16. 49qah60606
17. 5,7-trihydroxyflavone
18. Biacalein
19. Sho-saiko-to
20. Smr000112462
21. Sr-01000597499
22. Nsc 661431
23. Unii-49qah60606
24. Baicalein, 8
25. Baicalein,(s)
26. 3wl
27. Baicalein, 14
28. Baicalein, 98%
29. Spectrum_000427
30. Tocris-1761
31. Specplus_000758
32. Baicalein [mi]
33. Baicalein [inci]
34. Spectrum2_000466
35. Spectrum3_001608
36. Spectrum4_000537
37. Spectrum5_001418
38. Baicalein [usp-rs]
39. Baicalein [who-dd]
40. Oprea1_765614
41. Bspbio_003215
42. Kbiogr_001173
43. Kbioss_000907
44. Mls002473007
45. Mls006011756
46. Bidd:er0121
47. Divk1c_006854
48. Schembl139617
49. Spectrum1504002
50. Spbio_000572
51. Gtpl5144
52. Dtxsid2022389
53. Kbio1_001798
54. Kbio2_000907
55. Kbio2_003475
56. Kbio2_006043
57. Kbio3_002435
58. Hms1922o22
59. Hms2267f15
60. Hms3268c22
61. Hms3412f14
62. Hms3649o19
63. Hms3655p18
64. Hms3676f14
65. Albb-028286
66. Bcp14393
67. Hy-n0196
68. Tnp00121
69. Zinc3871633
70. Bbl027840
71. Bdbm50009001
72. Ccg-38705
73. Lmpk12111095
74. Nsc729192
75. S2268
76. Stl146746
77. Akos005747014
78. Ac-7991
79. Cs-6159
80. Nsc-729192
81. Sdccgmls-0066744.p001
82. Baicalein, Analytical Reference Material
83. Smp1_000037
84. Ncgc00017236-01
85. Ncgc00017236-02
86. Ncgc00017236-03
87. Ncgc00017236-04
88. Ncgc00017236-05
89. Ncgc00017236-06
90. Ncgc00017236-07
91. Ncgc00017236-08
92. Ncgc00017236-10
93. Ncgc00017236-11
94. Ncgc00025282-01
95. Ncgc00025282-02
96. Ncgc00025282-03
97. Ncgc00025282-04
98. Ncgc00178204-01
99. As-57923
100. Sy057137
101. 5,6,7-trihydroxy-2-phenyl-chroman-4-one
102. Ft-0622548
103. N1858
104. Sw219229-1
105. T2721
106. S00113
107. 491b678
108. 5,7-trihydroxy-2-phenyl-4h-1-benzopyran-4-one
109. A827663
110. Q-100550
111. Q2879363
112. Sr-01000597499-1
113. Sr-01000597499-3
114. Sr-01000597499-4
115. Sr-01000597499-6
116. W-202870
117. 5,6,7-trihydroxy-2-phenyl-(4h)-1-benzopyran-4-one
118. Brd-k72327355-001-02-2
119. Brd-k72327355-001-06-3
Molecular Weight | 270.24 g/mol |
---|---|
Molecular Formula | C15H10O5 |
XLogP3 | 1.7 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 270.05282342 g/mol |
Monoisotopic Mass | 270.05282342 g/mol |
Topological Polar Surface Area | 87 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 413 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Prostaglandin Antagonists
Compounds that inhibit the action of prostaglandins. (See all compounds classified as Prostaglandin Antagonists.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?